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Abstract 
Cerebral embolization is one of the most 
important procedures in 
neuroendovasculare intervention. Fast 
developments of new microcatheters that 
can be maneuvered endovascularly into the 
brain have permitted the treatment of 
lesions without conventional neurosurgery. 
Also, the progress in biomaterial science has 
contributed significantly to the 
development of this new therapeutic 
modality.  
Various embolic materials in clinical use 
are reviewed, such as cyanoacrylates, 
ethylene-vinyl alcohol copolymer mixtures, 
Ethibloc, ethanol, estrogen, poly(vinyl 
acetate), cellulose acetate polymer, 
poly(vinyl alcohol), gelatin sponges, 
microfibrillar collagen, surgical silk sutures, 
detachable balloons, and coils. These 
materials are reviewed in the context of 
treatment application for various brain 
lesions, such as arteriovenous 
malformations, cerebral aneurysms, and 
head and neck tumors. Further 
developments in biomaterial polymer 
science can bring about progress against 
brain diseases. 
Keywords: aneurysm, arteriovenous 
malformation, cerebral embolization, coils, 
embolic materials 
 
 
Introduction 
Cerebral embolization is defined as the 
"therapeutic introduction of various 
medical substances or devices into the brain 
circulation to occlude vessels or other 
vascular anomalies (aneurysms), either to 
arrest or prevent hemorrhaging; to 
devitalize a structure such as tumors, or to 
occlude its blood supply; to reduce blood 
flow to an arteriovenous malformation; to 
remodel a vascular wall or for a blood flow 
redirectionation. The procedure can be 
used as a single clinical therapy or in 
combination with other neurosurgical 
therapies (microsurgical resection or 
radiotherapy).  
Embolization, or embolotherapy, is 
performed in a special dedicated laboratory 
by neurosurgeons or neuroradiologists who 
have completed advanced postresidency 
training (fellowship) in neuroendovasculare 
intervention.  
After inserting a catheter into the target 
vessel, it is carried out by injecting or 
placing embolization materials via the 
catheter. Indications for arterial 
embolization include devascularization of 
tumors, control of hemorrhage, occlusion 
of arteriovenous malformation or 
aneurysms, ablation of an epileptic region, 
and redistribution of blood flow. Various 
embolization materials have been developed 
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and used in accordance with these 
purposes. 
Embolization materials clinically used 
are; metallic-coils, micro-coils, gelatin 
sponges, starch microspheres, auto-
agglutinated blood, dehydrated ethanol, 
NBCA, IBCA, lipiodol, embospheres, SAP-
MS, PVA, pluronic and gelatin particles. 
The choice of embolization material usually 
depends on the diameter of the vessel to be 
embolized and the expected duration of the 
embolic effect. Embolization of large, 
central vessels usually requires mechanical 
devices such as metallic coils or detachable 
balloons and particulate or liquid materials 
are required for small vessels close to the 
capillaries. In this exhibit, we will classify 
these materials into four types; mechanical 
devices, particulate, liquid agents and 
sclerosant agents and review these proper 
indications, uses and mechanisms of action. 
Some experimental results of newly 
developed embolization materials will be 
also shown.  
The materials are categorized as 
particulate, liquid, and mechanical in form, 
and as temporary and permanent in 
durability. The choice of embolization 
material depends on the size of the artery to 
be occluded and the duration of occlusion 
desired. The physical properties of 
embolization materials also should be 
considered. 
Embolization may have 3 therapeutic 
goals: 
1. An adjunctive goal (eg, preoperative, 
adjunct to chemotherapy or radiation 
therapy)   
2. A curative goal (eg, definitive 
treatment such as that performed in cases of 
aneurysms, arteriovenous fistulae [AVFs], 
arteriovenous malformations [AVMs], and 
traumatic bleeding)   
3. A palliative goal (eg, relieving 
symptoms, such as those of a large AVM, 
which cannot be cured by using 
embolotherapy alone) 
Medical conditions treated by using 
embolotherapy can be grouped as follows: 
1. Vascular anomalies (eg, AVM, AVF, 
venous malformation [VM], lymphatic 
malformation [LM], and hemangioma)  
2. Hemorrhage (eg, pseudoaneurysms 
and GI tract, pelvic, posttraumatic, 
epistaxis, and hemoptysis bleeding)  
3. Other conditions (eg, tumors, 
varicoceles, and organ ablation) 
Embolic agents 
Mechanical Devices 
Coils 
Endovascular coiling was introduced by 
Italian interventional neuroradiologist Dr. 
Guido Guglielmi at UCLA in 1991. It 
consists of passing a catheter into the 
femoral artery in the groin, through the 
aorta, into the brain arteries, and finally into 
the aneurysm itself. Once the catheter is in 
the aneurysm, platinum coils are pushed 
into the aneurysm and released.nA 
Guglielmi Detachable Coil, or GDC, is a 
platinum coil commonly used in 
intracranial non-invasive surgery for the 
occlusion of brain aneurysms. Guglielmi in 
1990, and was gradually introduced in the 
later 1990s as an alternative to surgical 
clipping, which requires invasive surgery. 
The GDC system consists of a soft 
platinum coil soldered to a stainless steel 
delivery wire. When the coil is properly 
positioned within the fundus a 1 mA 
current is applied to the delivery wire. The 
current dissolves the stainless steel delivery 
wire proximal to the platinum coil by 
means of electrolysis. At the same time, the 
positively charged platinum theoretically 
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attracts the negatively charged blood 
elements such as white and red blood cells, 
platelets, and fibrinogen thus inducing 
intra-aneurysmal thrombosis. Once 
electrolysis occurs the delivery wire can be 
removed leaving the coil in place. 
Mechanically and electronically detachable 
coils are currently available. 
The ball coils initiate a clotting or 
thrombotic reaction within the aneurysm 
that, if successful, will block the blood flow 
into the aneurysm and preventing rupture. 
In the case of broad-based aneurysms, a 
stent is passed first into the parent artery to 
serve as a scaffold for the coils ("stent-
assisted coiling"). 
Coils are made from stainless steel, 
platinum, or titanium wire to be visible via 
X-ray and be flexible enough to conform to 
the aneurysm shape. Most are coated with 
Dacron fibers to elicit greater thrombogenic 
reactions. Coils are made of soft platinum 
wire smaller than a strand of hair and are 
available in different diameters and lengths. 
All detachable coils are scientifically proven 
to be safe and effective. 
There are four types of coils (Figure 1):  
- bare platinum coils  
- coated platinum coils  
- biologically active coils.  
- radioactive coils 
The peculiarities of bare platinum coils 
lie in its physical as well as its electrolytical 
properties: The material has a high memory 
effect, allowing it to easily bend and regain 
its original coil shape. It is also highly 
sensitive to low currents, which allow the 
detach from the catheter that carries it, thus 
receiving the name of "detachable coil".  
Coils can be grouped into microcoils 
and macrocoils. Microcoils (platinum coils) 
can be delivered through microcatheters 
(2.2-3.5F). They can be particularly useful 
when superselective coil embolization is 
required. Microcoils are highly 
thrombogenic, radiopaque, and 
biocompatible. Collateralization is a 
potential disadvantage of coil embolization, 
and it can result in the persistence of flow 
into the vascular territory of the vessel that 
was embolized with the coil. Additionally, 
when proximal occlusion occurs with coil 
embolization, repeat intervention via the 
same artery becomes difficult, if not 
impossible. The most used bare platinum 
coils system used today are GDC coils from 
Boston Scientific, Micrus Coils and Trufill 
DCS Orbit Detachable Coil System from 
Codman Neurovascular.  
Macrocoils, also called, were first 
introduced in 1975. Coils have the 
advantage of being precisely positioned 
under fluoroscopic control. To increase the 
thrombogenic effect, Dacron wool tails are 
attached to coils. The coils are available in 
many sizes and may be delivered through 
commonly used angiographic catheters (4-
5F). 
Again, the thrombogenic effect primarily 
results from the addition of silk or synthetic 
fibers, not from the coil. 
Hydrogel-coated coil (HydroCoil 
Embolic System, MicroVention, Aliso 
Viejo, Calif) is one of the biologically active 
detachable coils that were developed to 
achieve more durable aneurysm occlusion 
by improved volumetric percentage 
occlusion of the aneurysmal cavity. The 
HydroCoil Embolic System 
(MicroVention) is a recently developed coil 
technology designed to improve packing 
density. Hydrogel-coated coils 
(HydroCoils) consist of platinum coils 
covered with a hydrophilic polymer that 
swells in blood.  
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Figure 1  A, B, C GDC Coils System; D: Coils de Gianturco; E: Flipper Detachable Coil; F: Nit-Occlud; G: 
Amplatzer Duct Occlud 
 
 
Figure 2  A HydroCoil Embolic System; B- Matrix Coils 
 
Coil swelling in vivo should theoretically 
result in greater aneurysm filling compared 
with inert platinum coils and may translate 
into more durable therapy (Figure 2A). 
Matrix Coils are platinum coils covered 
with an absorbable copolymer. They 
employ a proprietary outer copolymer coil 
over an inner platinum main coil. The 
copolymer runs the entire length of the 
main coil and constitutes approximately 
70% of total coil volume. The absorbable 
copolymer is typically absorbed by the body 
within 90 days. Matrix Coils employ a well-
characterized Polyglycolic-Polylactic Acid 
(PGLA) copolymer that has been used in 
many biocompatible devices, such as 
surgical staples, orthopedic implants, 
sutures, and drug delivery vehicles. Matrix 
Coils utilize electrolytic detachment for coil 
delivery. Because the electrolytic process 
does not rely on mechanical movement to 
deliver the coil, it provides precise, motion-
free detachment. Matrix Coils (Figure 2B). 
Stents 
An endovascular stent graft is a tube 
composed of fabric supported by a metal 
mesh called a stent.  It can be used for a 
variety of conditions involving the blood 
vessels, but in neurosurgery most 
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commonly is used to reinforce a weak spot 
in an artery (an aneurysm) or to re-establish 
the blood flow throw a stenosed vessel 
(Figure 3). The stent graft is designed to 
seal tightly with your artery above and 
below the aneurysm. The graft is stronger 
than the weakened artery and it allows your 
blood to pass through it without pushing 
on the bulge. 
Brain aneurysm stenting is performed 
when wide-necked brain aneurysms are 
treated with endovascular coils. Wide-
necked aneurysms are characterized by a 
large opening to the blood vessel on which 
they formed. The large opening makes 
these aneurysms prone to coil herniation, 
or displacement of coils from the aneurysm 
into the parent blood vessel. Coil herniation 
may cause serious complications. Stents are 
small, flexible, tube-like devices. A stent is 
placed across the aneurysm neck to keep 
coils inside the wide-necked brain 
aneurysm during treatment. In this 
procedure, the stent is intended to help 
hold the coils within the aneurysm to 
prevent coil herniation. So, after stent 
placement another catheter is then 
navigated through the deployed stent the 
aneurysm. Tiny platinum coils are threaded 
through the catheter and deployed into the 
aneurysm, blocking blood flow into the 
aneurysm and preventing rupture (Figure 4 
A, B). 
The severe clinical vasospasm due to 
aneurysmal subarachnoid haemorrhage or 
endovacular catheter and coil manipulation 
remains a great chaleange for 
neurointerventionist specialists. However, 
transluminal balloon angioplasty and the 
intraarterial stent placement represent 
successful tools in treating severe refractory 
cerebral vasospasm.  
 
Figure 3  Image of a stent with Rx markers (big 
arrow) and connection points (small arrow) 
 
 
A 
 
B 
Figure 4  Angiografic image of an PComA aneurysm 
embolized by stent and coil technique (A-with and 
B-with out contrast enhancement) 
 
Several clinical studies report also, the 
successful treatment of acute sinus 
thrombosis by sinus angioplasty with stent 
deployment. 
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The Neuroform stent is the first 
microcatheter-delivered stent designed 
specifically for the neuroendovascular 
treatment. The stent functions primarily to 
provide durable parent vessel protection 
during the embolization of broad-necked 
cerebral aneurysms. Neuroform3 Stents 
employ a highly flexible, hybrid cell design 
for better tracking during access and greater 
conformability within a variety of vessel 
morphologies. The Neuroform3 hybrid cell 
design is engineered to provide greater 
scaffolding for coil mass support and 
sufficient radial force to generate stability 
within the vessel. 
Baloon occlusion 
The concept of a catheter-delivered 
detachable balloon as a therapeutic 
cerebrovascular device is credited to 
Serbinenko. In North America, the 
technique (in various permutations) has 
been popularized by Debrun et al and 
Heishima et al for the treatment of direct 
carotid cavernous fistulas (CCFs) and by 
others for hunterian occlusion (after 
successful test occlusion) of giant, 
intracranial aneurysms(Figure 5).  
 
 
 
Figure 5  Detachable balloon inflated  
and deflated 
 
The detachable balloon catheter is 
comprised of latex detachable balloons 
having a hollow cylinder securely fastened 
at the neck or entrance to the balloon. A 
catheter tube is held inside the cylinder by a 
releasable retainer which permits 
atraumatic detachment of the catheter tube 
after placement of the balloon in a lesion. A 
seal means is installed inside the balloon for 
sealing the balloon after its placement and 
inflation. The releasable retainer permits 
atraumatic detachment by complete 
separation of the catheter tube from the 
balloon and its withdrawal after placement 
of the balloon without any force being 
applied to the arterial lesion. 
Detachable balloon occlusion may 
provide an alternative therapy for selected 
cases of direct arteriovenouse fistulas or 
difficult aneurysms. Under fluoroscopic 
visualization, a silicone balloon is flow-
directed through the intracranial circulation 
and guided directly into the aneurysm or 
region of aberrant connection between 
artery and vein. Using real-time subtraction 
or "road mapping" techniques, the balloon 
is inflated with a enhancement solution, 
hydrophilic polymer, hydroxyethyl 
methacrylate, which solidifies to create a 
permanent embolic agent. The balloon is 
then detached within the fistula or 
aneurysm, and angiography is done to 
confirm occlusion of the aneurysm with 
preservation of the parent artery (Figure 
6A). 
Ectatic aneurysms without a neck may 
be treated by occluding the aneurysm or the 
parent artery (or both). The procedures are 
done from a transfemoral approach using 
local anesthesia to permit continuous 
neurologic monitoring of the patient's 
condition. 
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A 
 
B 
Figure 6  A Grafic of a CCF balloon embolization, 
B Angiografy of  ICA aneurysm treated by ballon 
embolization 
 
The technique has been used to treat 
aneurysms of the proximal, mid, and 
distal basilar, posterior cerebral, lateral 
posterior choroidal, cavernous internal 
carotid, posterior communicating, carotid 
ophthalmic, carotid bifurcation, and 
middle cerebral arteries(Figure 6B). 
Although generally accepted as the 
method of choice for the treatment of 
direct CCFs, detachable balloon 
embolization in the CNS is a procedure of 
some complexity, with a potential for 
significant complications. Many factors 
influencing outcome bear on the critical 
timing of balloon detachment. Previous 
reports have emphasized detachment of 
these devices by means of a second, coaxial 
(4F over 2F) sleeve, which pushes the 
balloon off the delivery catheter, or by 
means of simple inflation and gentle 
traction on the delivery catheter (3). Poor 
tracking of the sleeve and inability to push 
the balloon into place may hamper the 
former method. The second technique is 
fraught with the risk of balloon migration 
(particularly into the carotid artery) at the 
time of detachment. 
Particulate 
Polyvinyl alcohol 
PVA is obtained by the reticulation of 
PVA (Ivalon) with formaldehyde. PVA is 
available as particles with a large range of 
sizes. For sizes as large as 710 μ m, a 
microcatheter can be used as a delivery 
catheter (Figure 7). 
Successful PVA-particle embolization 
depends on the formation of a thrombus in 
which a large proportion of the embolized 
vessel is filled with thrombus rather than 
PVA particles. Histologically, this agent 
causes intraluminal thrombosis associated 
with an inflammatory reaction, with 
subsequent organization of the thrombus. 
PVA is considered a permanent embolic 
agent because of the low frequency of 
recanalization of the embolized vessels. 
PVA is not absorbable, and it likely 
produces permanent occlusion. 
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Figure 7  CONTOUR microparticle for 
cerebral embolization 
 
PVA is usually administered in a mixture 
of contrast medium and isotonic sodium 
chloride solution under fluoroscopic 
guidance. Aggregation of PVA particles can 
be minimized by using dilute contrast 
medium in a matched-density suspension; 
for example, Omnipaque and sodium 
chloride solution can be used in a ratio of 
1:0.4 for contour particle suspension. PVA 
particles have a tendency to aggregate 
within the vessel once administered, 
potentially leading to an occlusion that is 
more proximal than intended. Diluted 
mixtures advance more distally, whereas 
concentrated mixtures cause more proximal 
occlusions. 
Tris-acryl gelatin microspheres 
Microspheres (Embosphere; Biosphere 
Medical, Rockland, Mass) are 
biocompatible, hydrophilic, nonresorbable, 
and precisely calibrated particles produced 
from an acrylic polymer and impregnated 
with porcine gelatin. Microspheres are 
available in sizes of 40-1200 μm, and they 
are supplied in apyrogenic sterile sodium 
chloride solution. 
To provide the desired clinical outcome, 
appropriately sized microspheres and 
delivery catheters must be chosen to best 
match the size of the target vessel. For 
example, when AVMs are being embolized, 
choose a particle size that occludes the 
nidus without passing into the systemic 
circulation. These particles typically do not 
aggregate, and this is a distinct advantage of 
microspheres compared with PVA particles. 
Microspheres can tolerate temporary 
compression of 20-30% to facilitate their 
passage through the delivery catheter. 
When a coaxial technique is used, a 2.5-
3.0F microcatheter allows the passage of 
microspheres as large as 700 μm for 
embolization. 
Because microspheres are not 
radiopaque, contrast enhancement must be 
used to monitor embolization under 
fluoroscopic guidance. Microspheres are 
considered permanent embolic particles. 
Gelfoam 
Gelfoam is a sterile gelatin sponge 
intended for application to bleeding 
surfaces for hemostasis or for use as a 
temporary intravascular embolic material. It 
is a water-insoluble, off-white, nonelastic, 
porous, and pliable material. Gelfoam may 
be cut without fraying, and it can absorb 
and hold many times its weight in blood 
and other fluids. 
Gelfoam is usually absorbed completely 
(depending on the amount used, degree of 
saturation with blood, and site at which it is 
used), with little tissue reaction. When used 
as an embolic material, the vessel 
recanalizes within a few weeks. Gelfoam is 
supplied in a sterile envelope enclosed in an 
outer peelable envelope. It is available in 
sizes from 12 mm to 6 cm. 
Liquid Agents 
Cyanoacrylate 
Cyanoacrylate, or N- -butyl-2-
cyanoacrylate (NBCA) is a rapidly 
hardening liquid adhesive often referred to 
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as glue. The substance hardens 
(polymerizes) immediately on contact with 
blood or other ionic fluid. Polymerization 
results in an exothermic reaction that 
destroys the vessel wall (Figure 8). 
Penetration of the capillary bed causes 
severe tissue injury. Because of the rapid 
polymerization, coaxial catheterization, 
precise positioning of the delivery catheter 
and considerable skill are required for 
NBCA embolization. When a suitable 
location is reached by using a 
microcatheter, the catheter is flushed with 
5% dextrose to clear it of any blood or 
contrast medium. 
Under real-time fluoroscopic control, a 
mixture of NBCA and oily contrast 
medium is delivered. As soon as a cast of 
the vascular tree is seen fluoroscopically, 
the delivery microcatheter is quickly 
removed so that the catheter tip does not 
adhere to the vessel. Again, the catheter is 
flushed quickly with 50% dextrose so that it 
can be reused during the same procedure. 
Onyx 
Onyx ((EVOH) is a bio-compatible 
liquid polymer that precipitates and 
solidifies in contact with blood, thus 
forming a soft and spongy embolus. The 
application of the ethylene-vinyl alcohol 
copolymer (EVOH) in the endovascular 
treatment of intracranial AVMs was first 
described by Taki et al7 and Terada et al8 in 
the early 1990s. A mixture of 60 parts of the 
solvent dimethyl-sulfoxide (DMSO), 5 
parts of EVOH, and 35 parts of the contrast 
agent metrizamide was used. EVOH is now 
commercially available as the nonadhesive 
liquid embolic system under the names 
Onyx 18, Onyx 20, and Onyx 34 (ev3, 
Irvine, Calif) and is CE-marked for the 
treatment of intracranial AVMs in Europe. 
 
Figure 8  GLUBRAN2 the second generation of 
cyanoacrylate liquid agent 
 
 
 
 
Figure 9  Angiography anterior and lateral view of 
an occipital AVM embolized with Onyx 
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Since July 2005, Onyx 18 and Onyx 34 
have been approved in the United States by 
the Food and Drug Administration. The 
numbers 18, 20, and 34 quantify the 
viscosity of Onyx in centipoises (cp). Onyx 
18 contains 6% EVOH and 94% DMSO, 
Onyx 20 6.5% EVOH and 93.5% DMSO, 
and Onyx 34 8% EVOH and 92% DMSO. 
Tantal powder is added to the mixture for 
radiopacity. 
Onyx must therefore be shaken for at 
least 20 minutes before injection to achieve 
homogeneous radiopacity of the mixture. 
DMSO is potentially angiotoxic, but this 
effect is negligible if used with the 
recommended infusion rates. If the mixture 
comes into contact with aqueous solutions, 
precipitation of the polymer is initiated by 
diffusion of DMSO. This process begins on 
the surface while the core is still liquid, 
resulting in a soft, nonadherent mass. 
Therefore, Onyx has a lavalike flow pattern 
within blood vessels without any 
fragmentation during the injection 
(Figure9). Due to these properties and 
because Onyx is not absorbable, it is capable 
of producing permanent vascular 
occlusion.11 Once the microcatheter is 
wedged into the Onyx cast around the tip 
of catheter, several compartments12 of the 
nidus can be embolized from a single 
catheter position. The embolized part of the 
nidus appears larger than the opacified part 
during selective contrast agent injections 
from the microcatheter. Because of the 
nonadhesive properties of Onyx, the 
injection can be interrupted to assess the 
progress of the embolization and can then 
be continued. 
Sclerosant Agents 
Ethanol 
Ethanol (absolute alcohol) is the most 
commonly used liquid agent. Embolization 
with absolute alcohol has a direct toxic 
effect on the endothelium that activates the 
coagulation system and causes the 
microaggregation of red blood cells. 
In the treatment of vascular 
malformations, ethanol has demonstrated 
its curative potential compared with the 
palliative effect seen with other embolic 
agents. Occlusion of the lumen occurs 
within minutes or days. Ethanol can be 
damaging if it reaches the capillary bed of 
any given tissue (eg, skin), and it usually 
causes significant soft-tissue swelling, 
which may subsequently cause 
compartment syndrome (nerve 
compression). 
When absolute alcohol is mixed with a 
contrast medium and when small catheters 
are used, superselective vascular 
embolization can be safely performed under 
fluoroscopic guidance. Ethiodized oil 
(Ethiodol), an oily contrast medium, is used 
most commonly. 
If large amounts of absolute alcohol 
enter the systemic circulation, toxic effects 
can occur. These include central nervous 
system (CNS) depression, hemolysis, and 
cardiac arrest. Slow, careful injections by 
using balloon occlusion arterial catheters 
for delivery and by applying manual 
compression on the draining veins (or 
tourniquet control) or balloon occlusion of 
the draining system may decrease alcohol 
washout from the lesion and reduce acute 
systemic toxicity. Ethanol 1 mg/kg is the 
maximum amount that can be injected 
during a single session. 
Sodium tetradecyl sulfate 
Sodium tetradecyl sulfate (Sotradecol) is 
another sclerosant. This contains 2% benzyl 
alcohol and is commonly used for VMs and 
varices. Use of this agent is less painful for 
the patient, and it is considered to be less 
toxic then absolute alcohol. Therefore, 
some lesions can be treated without general 
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anesthesia. 
Sodium tetradecyl sulfate can be used as 
a sclerosant in various concentrations (1-
3%); however, manufacture of this agent 
has been discontinued in the United States. 
This author has begun using ethanolamine 
oleate (Ethamolin; Questcor 
Pharmaceuticals, Hayward, Calif) instead of 
sodium tetradecyl, with the same 
indications. 
Other materials 
Other less commonly or previously used 
materials include balloons, microfibrillar 
collagen (Avitene), autologous materials, 
ethylene vinyl alcohol, alginates, 
phosphoryl choline, sodium morrhuate, hot 
contrast material, and 50% dextrose. 
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